TY - JOUR
T1 - Association of amyloid angiopathy with microbleeds in logopenic progressive aphasia
T2 - an imaging-pathology study
AU - Buciuc, M.
AU - Duffy, J. R.
AU - Machulda, M. M.
AU - Spychalla, A. J.
AU - Gunter, J. L.
AU - Jack, C. R.
AU - Giannini, C.
AU - Raghunathan, A.
AU - Dickson, D. W.
AU - Josephs, K. A.
AU - Whitwell, J. L.
N1 - Funding Information:
This study was funded by National Institutes of Health grants: R01‐DC10367, NIRG‐12‐242215, R01‐AG50603. These grants served for the design and conduct of the study, collection, management and analysis of the collected data. The sponsor had no role in study design; collection, analysis and interpretation of data; writing the report; or in the decision to submit the article for publication.
Publisher Copyright:
© 2020 European Academy of Neurology
PY - 2021/2
Y1 - 2021/2
N2 - Background and purpose: Cerebral microbleeds (MB) and superficial siderosis (SS) are frequent neuroimaging findings in patients with logopenic progressive aphasia (LPA), often with frontal lobe predilection. Cerebral amyloid angiopathy (CAA) is hypothesized to be the major pathologic determinant of MB/SS in these patients; however, neuroimaging-pathologic data are limited. Methods: All patients who had been prospectively recruited by the Neurodegenerative Research Group at the Mayo Clinic (Rochester, MN) between 2010 and 2015 and met the following inclusion criteria were included: (i) received an antemortem LPA diagnosis, (ii) had a gradient-recalled echo T2*-weighted magnetic resonance imaging (MRI) performed, (iii) died and completed a brain autopsy. Demographic, genetic, neuroimaging, and clinical and pathologic characteristics were compared between patients with/without MB/SS. Two-tailed Fisher exact and Wilcoxon rank sum tests were used for comparison of categorical and continuous variables, respectively. Results: Thirteen patients met inclusion criteria, six (46%) had MB/SS on MRI. Moderate/severe CAA was associated with the presence of MB/SS (p = 0.029). As expected, MB/SS most frequently involved the frontal lobes, followed by the parietal lobes. No clear associations were found between regional MB/SS distribution and regional distribution of CAA or hypometabolism on [18F]-fluorodeoxyglucose–positron emission tomography. There was some evidence for a regional association between MB/SS and uptake on Pittsburgh compound B, although not in all patients. No formal statistical analyses to assess topographic relationships were performed due to the small sample size. Conclusions: The presence of MB/SS is a strong indicator of underlying moderate/severe CAA in LPA, although the biological mechanisms underlying the topographic distribution of MB/SS remain unclear.
AB - Background and purpose: Cerebral microbleeds (MB) and superficial siderosis (SS) are frequent neuroimaging findings in patients with logopenic progressive aphasia (LPA), often with frontal lobe predilection. Cerebral amyloid angiopathy (CAA) is hypothesized to be the major pathologic determinant of MB/SS in these patients; however, neuroimaging-pathologic data are limited. Methods: All patients who had been prospectively recruited by the Neurodegenerative Research Group at the Mayo Clinic (Rochester, MN) between 2010 and 2015 and met the following inclusion criteria were included: (i) received an antemortem LPA diagnosis, (ii) had a gradient-recalled echo T2*-weighted magnetic resonance imaging (MRI) performed, (iii) died and completed a brain autopsy. Demographic, genetic, neuroimaging, and clinical and pathologic characteristics were compared between patients with/without MB/SS. Two-tailed Fisher exact and Wilcoxon rank sum tests were used for comparison of categorical and continuous variables, respectively. Results: Thirteen patients met inclusion criteria, six (46%) had MB/SS on MRI. Moderate/severe CAA was associated with the presence of MB/SS (p = 0.029). As expected, MB/SS most frequently involved the frontal lobes, followed by the parietal lobes. No clear associations were found between regional MB/SS distribution and regional distribution of CAA or hypometabolism on [18F]-fluorodeoxyglucose–positron emission tomography. There was some evidence for a regional association between MB/SS and uptake on Pittsburgh compound B, although not in all patients. No formal statistical analyses to assess topographic relationships were performed due to the small sample size. Conclusions: The presence of MB/SS is a strong indicator of underlying moderate/severe CAA in LPA, although the biological mechanisms underlying the topographic distribution of MB/SS remain unclear.
KW - atypical Alzheimer’s disease
KW - cerebral amyloid angiopathy
KW - logopenic progressive aphasia
KW - magnetic resonance imaging
KW - microbleeds
KW - positron emission tomography
UR - http://www.scopus.com/inward/record.url?scp=85097012866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097012866&partnerID=8YFLogxK
U2 - 10.1111/ene.14594
DO - 10.1111/ene.14594
M3 - Article
C2 - 33068458
AN - SCOPUS:85097012866
SN - 1351-5101
VL - 28
SP - 670
EP - 675
JO - European Journal of Neurology
JF - European Journal of Neurology
IS - 2
ER -